Boston Scientific Gain (Loss) on Investments decreased by 27.9% to $158.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 664.3%, from -$28.00M to $158.00M. Over 2 years (FY 2021 to FY 2024), Gain (Loss) on Investments shows a downward trend with a -45.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive values indicate successful investment management, while negative values reflect market volatility or poor asset selection.
This reflects the realized gains or losses from the sale of investment assets, such as bonds or equities, held by the co...
Common for insurance and financial firms with large investment portfolios.
operating_gain_loss_on_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $186.00M | $42.00M | -$20.00M | -$16.00M | -$10.00M | -$31.00M | -$4.00M | -$13.00M | -$11.00M | -$2.00M | -$44.00M | -$14.00M | -$19.00M | -$28.00M | $219.00M | $158.00M |
| QoQ Change | — | — | -77.4% | -147.6% | +20.0% | +37.5% | -210.0% | +87.1% | -225.0% | +15.4% | +81.8% | <-999% | +68.2% | -35.7% | -47.4% | +882.1% | -27.9% |
| YoY Change | — | — | — | — | — | -105.4% | -55.0% | +75.0% | -30.0% | — | +93.5% | <-999% | -7.7% | -72.7% | <-999% | +597.7% | +664.3% |